BRITAIN'S Medicines and Healthcare products Regulatory Agency (MHRA) has approved an antimalarial tablet which will be available through UK pharmacies without prescription.
Sold under the brand name Maloff Protect, the tablets contain two antimalarial agents, atovaquone and proguanil.
"Pharmacists will be able to advise if Maloff Protect is suitable to protect from malaria depending on which countries are being visited, pre-existing medical conditions, and any other medicines being taken," an MHRA spokesperson said.
"Pharmacists will also be best placed to advise how to avoid mosquito bites, such as the use of bed nets, repellent sprays and appropriate clothing when outside.
"They will also be able to reinforce the importance of seeking a full travel consultation, including the need for travel vaccinations."
The MHRA has said it is considering a number of items for reclassification as OTC medicine, to help widen access to products for the benefit of public health when considered safe.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jul 17